NDC Package 41701-013-72 Leuprolide Acetate

Powder - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
41701-013-72
Package Description:
1 BOTTLE in 1 BOTTLE / 37 g in 1 BOTTLE (41701-013-71)
Product Code:
Non-Proprietary Name:
Leuprolide Acetate
Substance Name:
Leuprolide Acetate
Usage Information:
Leuprolide is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment.
11-Digit NDC Billing Format:
41701001372
Product Type:
Bulk Ingredient
Labeler Name:
Piramal Pharma Limited
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Sample Package:
N/A
Marketing Category:
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date:
03-18-2011
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
41701-013-101 BOTTLE in 1 BOTTLE / 250 g in 1 BOTTLE (41701-013-09)
41701-013-121 BOTTLE in 1 BOTTLE / 139 g in 1 BOTTLE (41701-013-11)
41701-013-201 BOTTLE in 1 BOTTLE / 252 g in 1 BOTTLE (41701-013-19)
41701-013-241 BOTTLE in 1 BOTTLE / 217 g in 1 BOTTLE (41701-013-23)
41701-013-261 BOTTLE in 1 BOTTLE / 295 g in 1 BOTTLE (41701-013-25)
41701-013-301 BOTTLE in 1 BOTTLE / 10 g in 1 BOTTLE (41701-013-29)
41701-013-381 BOTTLE in 1 BOTTLE / 257 g in 1 BOTTLE (41701-013-37)
41701-013-401 BOTTLE in 1 BOTTLE / 243 g in 1 BOTTLE (41701-013-39)
41701-013-421 BOTTLE in 1 BOTTLE / 50 g in 1 BOTTLE (41701-013-41)
41701-013-441 BOTTLE in 1 BOTTLE / 87.5 g in 1 BOTTLE (41701-013-43)
41701-013-461 BOTTLE in 1 BOTTLE / 139 g in 1 BOTTLE (41701-013-45)
41701-013-481 BOTTLE in 1 BOTTLE / 286 g in 1 BOTTLE (41701-013-47)
41701-013-501 BOTTLE in 1 BOTTLE / 222 g in 1 BOTTLE (41701-013-49)
41701-013-521 BOTTLE in 1 BOTTLE / 100 g in 1 BOTTLE (41701-013-51)
41701-013-541 BOTTLE in 1 BOTTLE / 111 g in 1 BOTTLE (41701-013-53)
41701-013-571 BOTTLE in 1 BOTTLE / 156 g in 1 BOTTLE (41701-013-56)
41701-013-601 BOTTLE in 1 BOTTLE / 86.5 g in 1 BOTTLE (41701-013-59)
41701-013-621 BOTTLE in 1 BOTTLE / 135 g in 1 BOTTLE (41701-013-61)
41701-013-641 BOTTLE in 1 BOTTLE / 57 g in 1 BOTTLE (41701-013-63)
41701-013-661 BOTTLE in 1 BOTTLE / 170 g in 1 BOTTLE (41701-013-65)
41701-013-681 BOTTLE in 1 BOTTLE / 157 g in 1 BOTTLE (41701-013-67)
41701-013-701 BOTTLE in 1 BOTTLE / 154 g in 1 BOTTLE (41701-013-69)
41701-013-741 BOTTLE in 1 BOTTLE / 180 g in 1 BOTTLE (41701-013-73)
41701-013-761 BOTTLE in 1 BOTTLE / 80 g in 1 BOTTLE (41701-013-75)
41701-013-781 BOTTLE in 1 BOTTLE / 232 g in 1 BOTTLE (41701-013-77)
41701-013-801 BOTTLE in 1 BOTTLE / 240 g in 1 BOTTLE (41701-013-79)
41701-013-821 BOTTLE in 1 BOTTLE / 74 g in 1 BOTTLE (41701-013-81)
41701-013-841 BOTTLE in 1 BOTTLE / 64 g in 1 BOTTLE (41701-013-83)
41701-013-861 BOTTLE in 1 BOTTLE / 96 g in 1 BOTTLE (41701-013-85)
41701-013-881 BOTTLE in 1 BOTTLE / 164 g in 1 BOTTLE (41701-013-87)
41701-013-901 BOTTLE in 1 BOTTLE / 198 g in 1 BOTTLE (41701-013-89)
41701-013-921 BOTTLE in 1 BOTTLE / 215 g in 1 BOTTLE (41701-013-91)
41701-013-941 BOTTLE in 1 BOTTLE / 221 g in 1 BOTTLE (41701-013-93)
41701-013-961 BOTTLE in 1 BOTTLE / 119 g in 1 BOTTLE (41701-013-95)
41701-013-981 BOTTLE in 1 BOTTLE / 142 g in 1 BOTTLE (41701-013-97)

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 41701-013-72?

The NDC Packaged Code 41701-013-72 is assigned to an UNFINISHED drug package of 1 bottle in 1 bottle / 37 g in 1 bottle (41701-013-71) of Leuprolide Acetate, a bulk ingredient labeled by Piramal Pharma Limited. The product's dosage form is powder and is administered via form.

Is NDC 41701-013 included in the NDC Directory?

Yes, Leuprolide Acetate is an UNFINISHED PRODUCT with code 41701-013 that is active and included in the NDC Directory. The product was first marketed by Piramal Pharma Limited on March 18, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 41701-013-72?

The 11-digit format is 41701001372. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-241701-013-725-4-241701-0013-72